Author:
Lorenzi Marco,Filippone Maurizio,Frisoni Giovanni B.,Alexander Daniel C.,Ourselin Sebastien
Funder
EPSRC
European Union's Horizon 2020
AXA Research Fund
Alzheimer’s Disease Neuroimaging Initiative
National Institutes of Health
DOD ADNI (Department of Defense
National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech; BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Eisai
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
ADNI clinical sites in Canada
Northern California Institute for Research and Education
Subject
Cognitive Neuroscience,Neurology
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献